Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
WHO sets out concerns over US vaccine trial in G.Bissau

WHO sets out concerns over US vaccine trial in G.Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

UN agency recognizes 13 Guinea-Bissau communities as "FAO Villages"

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Opinion: When will we stop using Black bodies as research subjects?

Opinion: When will we stop using Black bodies as research subjects?

Neutral The San Diego Union-Tribune - California
Owner: Randall D. Smith & Heath Freeman
WHO sets out concerns over US vaccine trial in G.Bissau

WHO sets out concerns over US vaccine trial in G.Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

UN agency recognizes 13 Guinea-Bissau communities as "FAO Villages"

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Guinea-Bissau suspends US-funded vaccine trial as African scientists question its motives

Guinea-Bissau suspends US-funded vaccine trial as African scientists question its motives

Opinion: When will we stop using Black bodies as research subjects?

Opinion: When will we stop using Black bodies as research subjects?

Babies as ‘guinea pigs’: A vaccine trial in Guinea-Bissau comes under intense scrutiny

Babies as ‘guinea pigs’: A vaccine trial in Guinea-Bissau comes under intense scrutiny

Show More

Video Stories

YouTube video thumbnail: How Do Religions in Africa Coexist?
Play
How Do Religions in Africa Coexist?
YouTube video thumbnail: African Union Adopts Resolution Describing Slavery and Colonisation as Crimes Against Humanity
Play
African Union Adopts Resolution Describing Slavery and Colonisation as Crimes Against Humanity
YouTube video thumbnail: China to Scrap Tariffs for Most of Africa From 1 May, Says Xi Jinping
Play
China to Scrap Tariffs for Most of Africa From 1 May, Says Xi Jinping
YouTube video thumbnail: African Union Summit Confronts Worsening Conflicts
Play
African Union Summit Confronts Worsening Conflicts

Video Title

Press Releases

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions